NASDAQ:BCAB

Bioatla Stock Insider Trading

etoro logo Buy BCAB
*Your capital is at risk
$3.29
-0.0900 (-2.66%)
At Close: Jul 31, 2026

BioAtla Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.51. In total, the insiders bought 2.97M and sold 241.51K BCAB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.51
Buy 2.97M shares
Sell 241.51K shares
35% Buy Activity
Moderate Negative Correlation
Buy Signal Medium Confidence
Mar 11, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 99.51.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Mar 11, 2025
Buy
Common Stock
A-Award
Sievers Eric
Chief Medical Officer
Officer 175 000
Value: $2.69M
Mar 11, 2025
Buy
Common Stock
A-Award
Waldron Richard A
Chief Financial Officer
C-Suite Officer 100 000
Value: $1.54M
Mar 11, 2025
Buy
Common Stock
A-Award
Vasquez Christian
See Remarks
Officer 85 000
Value: $1.31M
Feb 16, 2025
Sell
Common Stock
F-InKind
Short Jay M Phd
Chief Executive Officer
CEO / President 30 911
Value: $14.2K
Feb 16, 2025
Sell
Common Stock
F-InKind
Short Jay M Phd
Chief Executive Officer
CEO / President 30 911
Value: $14.2K
Feb 15, 2025
Sell
Common Stock
F-InKind
Sievers Eric
Chief Medical Officer
Officer 12 530
Value: $6K
Feb 15, 2025
Sell
Common Stock
F-InKind
Waldron Richard A
Chief Financial Officer
C-Suite Officer 10 887
Value: $5K
Feb 15, 2025
Sell
Common Stock
F-InKind
Vasquez Christian
See Remarks
Officer 7 189
Value: $3K
Feb 15, 2025
Sell
Common Stock
F-InKind
Sievers Eric
Chief Medical Officer
Officer 12 530
Value: $6K
Feb 15, 2025
Sell
Common Stock
F-InKind
Vasquez Christian
See Remarks
Officer 7 189
Value: $3K
Feb 15, 2025
Sell
Common Stock
F-InKind
Waldron Richard A
Chief Financial Officer
C-Suite Officer 10 887
Value: $5K
Aug 31, 2024
Sell
Common Stock
F-InKind
Smith Scott Andrew
Director
Director 2 181
Value: $4K
Aug 31, 2024
Sell
Common Stock
F-InKind
Sievers Eric
Chief Medical Officer
Officer 572
Value: $1K
Aug 31, 2024
Sell
Common Stock
F-InKind
Sievers Eric
Chief Medical Officer
Officer 572
Value: $1K
Aug 31, 2024
Sell
Common Stock
F-InKind
Smith Scott Andrew
Director
Director 2 181
Value: $4K
Jul 31, 2024
Sell
Common Stock
F-InKind
Smith Scott Andrew
Director
Director 2 181
Value: $4K
Jul 31, 2024
Sell
Common Stock
F-InKind
Sievers Eric
Chief Medical Officer
Officer 572
Value: $1K
Jul 31, 2024
Sell
Common Stock
F-InKind
Sievers Eric
Chief Medical Officer
Officer 572
Value: $1K
Jul 31, 2024
Sell
Common Stock
F-InKind
Smith Scott Andrew
Director
Director 2 181
Value: $4K
Jun 30, 2024
Sell
Common Stock
F-InKind
Smith Scott Andrew
Director
Director 2 181
Value: $3K
Jun 30, 2024
Sell
Common Stock
F-InKind
Sievers Eric
Chief Medical Officer
Officer 572
Value: $784
Jun 30, 2024
Sell
Common Stock
F-InKind
Sievers Eric
Chief Medical Officer
Officer 572
Value: $784
Jun 30, 2024
Sell
Common Stock
F-InKind
Smith Scott Andrew
Director
Director 2 181
Value: $3K
Jun 13, 2024
Buy
Common Stock
A-Award
Gray Mary Ann
Director
Director 16 500
Value: $0
Jun 13, 2024
Buy
Common Stock
A-Award
Mcbrinn Sylvia
Director
Director 16 500
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BIOATLA, INC.
BioAtla
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, mel...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE